To the Commissioners of the SEC:
The minority shareholders of NanoViricides,Inc., of Shelton, CT, a listed company on the NYSE-American stock exchange (symbol NNVC) have been DEFRAUDED by the husband and wife team of Dr Anil R Diwan, CEO, President and Board Chairman, and his wife, Meeta Vyas, the CFO, ON A CONTINUING BASIS SINCE SEPTEMBER 1, 2005.
We are now in a CRISIS MODE attempting to alert the Division of Enforcement to this "FRAUD OF THIS CENTURY" perpetrated by these two totally corrupt individuals, and abetted by a subservient BOD of 3 men named Glick, Kulkarni, and Saperstein.
We filed a Whistleblower's Report on November 17, 2018 with your organization, having earlier filed with Senator Rubio's office in Orlando, FL on November 13, 2018, DESPERATELY TRYING TO GET YOUR ATTENTION.
NOTHING HAS WORKED TO THIS POINT.
The 10-Q for the December 31, 2018 quarter was filed last night by the husband/wife pair of fraudsters, and the same LIES THAT HAVE RIDDLED EARLIER FILINGS WERE CONTINUED VERBATIM.
PLEASE EXCUSE WHAT WE ARE FORCED TO DO TO GET YOUR ATTENTION: WE THE WHISTLEBLOWER TEAM AT NNVC ARE ASKING A GROUP OF INVESTORS THAT WE REPRESENT TO INDIVIDUALLY RESEND THIS PLEA FOR HELP TO YOU THIS MORNING TO YOUR RESPECTIVE SEC EMAIL ADDRESSES. IN ADDITION WE ARE POSTING THIS MESSAGE ON THE SILICON INVESTOR MESSAGE BOARD REQUESTING ANY WHO READ THIS MESSAGE TO YOU TO DO THE SAME.
We have spent the last 2 of 5 years documenting the degree of INTENTIONAL FRAUD AND GROSS MISMANAGEMENT on a DAILY BASIS. WE HAVE A WELL ORGANIZED PAPER TRAIL OF EMAILS THAT WE WILL SEND TO THE ATTORNEYS YOU ASSIGN TO THIS CASE, FOCUSING ON HOW WE UNCOVERED THE FRAUD ON SEPTEMBER 25, 2018, AND OUR REPEATED ATTEMPTS TO ALERT THE 3 INDEPENDENT DIRECTORS SINCE THAT DATE TO TERMINATE DR DIWAN FOR "CAUSE", TO NO AVAIL.
Please have your lead attorney email me a morsedavid2841@gmail.com with an address to send the evidence cache. For the record, EVERY INVESTOR WHO HAS BOUGHT STOCK IN THIS COMPANY IN THE IPO ON MAY 28, 2005 OR SINCE THAT DATE IN THE OPEN MARKET HAS LOST OVER 98% OF THEIR INVESTED CAPITAL BECAUSE OF THIS FRAUD. IRONICALLY, THE UNDERLYING TECHNOLOGY IS WORLD-CLASS, PRECISELY THE REASON FOR THE FRAUD IN THE FIRST PLACE.
Sincerely,
Dianne B
David Morse
The Whistleblower Team at Nanoviricides, Inc. (NNVC)
Filed with the SEC on November 17, 2018
Certification
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Anil Diwan, certify that:
| | 1. | I have reviewed this quarterly report on Form 10-Q of NanoViricides, Inc.; |
| | 2. | Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; |
| | 3. | Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; |
| | 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have: |
| | a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
| | b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| | c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based on such evaluation; and |
| | d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal over financial reporting; |
| | 5. | I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions): |
| | a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| | b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: February 14, 2019 | | | | /s/ Anil Diwan | | | Name: Anil Diwan | | | Title: President | | | (Principal Executive Officer) |
Exhibit 31.2
Certification
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Meeta Vyas, certify that:
| | 1. | I have reviewed this quarterly report on Form 10-Q of NanoViricides, Inc.; |
| | 2. | Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report; |
| | 3. | Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report; |
| | 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have: |
| | a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared; |
| | b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
| | c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based on such evaluation; and |
| | d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal over financial reporting; |
| | 5. | The registrant’s other certifying officer and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions): |
| | a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
| | b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: February 14, 2019 | | | | /s/ Meeta Vyas | | | Name: Meeta Vyas | | | Title: Chief Financial Officer, | | | (Principal Accounting and Financial Officer) |
|
